A group at NIMS MANA has developed tissue adhesive porous films that promote angiogenesis without using growth factors. This new technology may contribute to medical cost reduction while maintaining the quality of medical ...
Biochemistry
Aug 28, 2015
0
25
A University of Missouri researcher believes there could be a new drug compound that could kill breast cancer cells. The compound might also help with controlling cholesterol.
Biotechnology
Feb 22, 2011
0
0
Scientists at the Institute for Research in Biomedicine (IRB Barcelona) and CSIC report on the formation of the small-diameter respiratory tubes of the fly Drosophila, a process that resembles the development of the finest ...
Cell & Microbiology
Feb 09, 2010
0
0
A world-renowned medical researcher discusses the key role that nanotechnology has begun to play in the detection and treatment of cancer in an article that will appear in the March 2010 edition of Mechanical Engineering ...
Bio & Medicine
Feb 05, 2010
0
0
A breakthrough discovery by scientists at the University of Kentucky could someday lead to new treatments for a variety of diseases of the brain, spinal cord and the eye.
Biochemistry
Jan 15, 2010
0
0
MIT engineers have boosted stem cells' ability to regenerate vascular tissue (such as blood vessels) by equipping them with genes that produce extra growth factors (naturally occurring compounds that stimulate tissue growth). ...
Biotechnology
Oct 05, 2009
0
0
(PhysOrg.com) -- Adah Almutairi, Ph.D., assistant professor in the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego, is first author of a paper recently published in the Proceedings ...
Bio & Medicine
Jan 15, 2009
0
0
Angiogenesis is the physiological process involving the growth of new blood vessels from pre-existing vessels. Though there has been some debate over terminology, vasculogenesis is the term used for spontaneous blood-vessel formation, and intussusception is the term for the formation of new blood vessels by the splitting of exisiting ones.
Angiogenesis is a normal and vital process in growth and development, as well as in wound healing and in granulation tissue. However, it is also a fundamental step in the transition of tumors from a dormant state to a malignant one, leading to the use of angiogenesis inhibitors. The identification of an angiogenic diffusible factor derived from tumors was made initially by Greenblatt and Shubik in 1968.
This text uses material from Wikipedia, licensed under CC BY-SA
